Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

ResMed (RMD) News Today

ResMed logo
$252.79 -0.27 (-0.11%)
Closing price 03:59 PM Eastern
Extended Trading
$252.84 +0.06 (+0.02%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ResMed Latest News

ResMed (RMD) Projected to Release Quarterly Earnings on Thursday
ResMed (RMD) Projected to Release Earnings on Thursday
ResMed Inc. (NYSE:RMD) Stock Has Consensus Price Target of $243.23
ETFs Are Net Sellers of ResMed (RMD) on Oct. 16
Mizuho Adjusts Price Target on ResMed to $240 From $235
ResMed (NYSE:RMD) CEO Sells 4,991 Shares of Company Stock
ResMed CFO Awarded Performance-Based Equity Grant
Is the ResMed share price a cheap buy?
ResMed Inc. $RMD Shares Purchased by State Street Corp
ResMed Inc. $RMD Shares Sold by Baird Financial Group Inc.
Michael Farrell Sells 4,991 Shares of ResMed (NYSE:RMD) Stock
ResMed: A Significant Upside Despite The Perceived Risk
Peter Farrell Sells 970 Shares of ResMed (NYSE:RMD) Stock

ResMed Media Mentions By Week

ResMed Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RMD
News Sentiment
▼
0.28

0.48
▲
Average
Healthcare
News Sentiment

ResMed News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RMD Articles
This Week
▼
10

6
▲
RMD Articles
Average Week

ResMed Trends on MarketBeat

This week vs. last week
New Followers
1
-50%
Searches
2
+100%
Page Views
3,802
-5%
Get ResMed News Delivered to You Automatically

Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for ResMed dated 10/23/2026.
From Our Partners